Cargando…

Vascular-targeted photodynamic therapy with BF2-chelated Tetraaryl-Azadipyrromethene agents: a multi-modality molecular imaging approach to therapeutic assessment

BACKGROUND: Photodynamic therapy (PDT) is a treatment modality for a range of diseases including cancer. The BF(2)-chelated tetraaryl-azadipyrromethenes (ADPMs) are an emerging class of non-porphyrin PDT agent, which have previously shown excellent photochemical and photophysical properties for ther...

Descripción completa

Detalles Bibliográficos
Autores principales:	Byrne, A T, O'Connor, A E, Hall, M, Murtagh, J, O'Neill, K, Curran, K M, Mongrain, K, Rousseau, J A, Lecomte, R, McGee, S, Callanan, J J, O'Shea, D F, Gallagher, W M
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2009
Materias:	Translational Therapeutics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2778519/ https://www.ncbi.nlm.nih.gov/pubmed/19826417 http://dx.doi.org/10.1038/sj.bjc.6605247

Ejemplares similares

Identifying STEDable BF(2)-Azadipyrromethene Fluorophores
por: Curtin, Niamh, et al.
Publicado: (2023)

BF(2)-Azadipyrromethene Fluorophores for Intraoperative Vital Structure Identification
por: Caulfield, Cathal, et al.
Publicado: (2023)

Substituent directed cellular imaging in the 800–850 nm range with BF(2)-azadipyrromethene fluorophores
por: Caulfield, Cathal, et al.
Publicado: (2023)

Dual Color Imaging from a Single BF(2)-Azadipyrromethene Fluorophore Demonstrated in vivo for Lymph Node Identification
por: Curtin, Niamh, et al.
Publicado: (2021)

A potent nonporphyrin class of photodynamic therapeutic agent: cellular localisation, cytotoxic potential and influence of hypoxia
por: Gallagher, W M, et al.
Publicado: (2005)

Mechanosynthesis of Odd‐Numbered Tetraaryl[n]cumulenes
por: Ardila‐Fierro, Karen J., et al.
Publicado: (2019)

Synthesis and characterization of fluorinated azadipyrromethene complexes as acceptors for organic photovoltaics
por: Etheridge, Forrest S, et al.
Publicado: (2016)

Enhanced effects of aminolaevulinic acid-based photodynamic therapy through local hyperthermia in rat tumours
por: Kelleher, D K, et al.
Publicado: (2003)

Enhanced photodynamic destruction of a transplantable fibrosarcoma using photochemical internalisation of gelonin
por: Dietze, A, et al.
Publicado: (2005)

Combined hyperthermia and chlorophyll-based photodynamic therapy: tumour growth and metabolic microenvironment
por: Kelleher, D K, et al.
Publicado: (2003)

A Chemiluminescent Tetraaryl Diborane(4) Tetraanion
por: Budy, Hendrik, et al.
Publicado: (2021)

Foscan® uptake and tissue distribution in relation to photodynamic efficacy
por: Cramers, P, et al.
Publicado: (2003)

Differentiation enhances aminolevulinic acid-dependent photodynamic treatment of LNCaP prostate cancer cells
por: Ortel, B, et al.
Publicado: (2002)

Verteporfin- and sodium porfimer-mediated photodynamic therapy enhances pancreatic cancer cell death without activating stromal cells in the microenvironment
por: Lu, Jingjing, et al.
Publicado: (2019)

Peripheral neural cell sensitivity to mTHPC-mediated photodynamic therapy in a 3D in vitro model
por: Wright, K E, et al.
Publicado: (2009)

Bax is essential for mitochondrion-mediated apoptosis but not for cell death caused by photodynamic therapy
por: Chiu, S-M, et al.
Publicado: (2003)

Interrogation of gossypol therapy in glioblastoma implementing cell line and patient-derived tumour models
por: Jarzabek, M A, et al.
Publicado: (2014)

Connect Four: Tetraarylated Dihydropentalenes and Triarylated Monocyclic Pentafulvenes from Cyclopentadienes and Enones
por: Jenek, Niko A., et al.
Publicado: (2022)

Methotrexate used in combination with aminolaevulinic acid for photodynamic killing of prostate cancer cells
por: Sinha, A K, et al.
Publicado: (2006)

Photodynamic therapy augments the efficacy of oncolytic vaccinia virus against primary and metastatic tumours in mice
por: Gil, M, et al.
Publicado: (2011)

Single-Molecule Force Spectroscopy of a Tetraaryl Succinonitrile Mechanophore
por: van Galen, Martijn, et al.
Publicado: (2022)

Ischaemia-reperfusion injury in photodynamic therapy-treated mouse tumours
por: Korbelik, M, et al.
Publicado: (2003)

Effects of light fractionation and different fluence rates on photodynamic therapy with 5-aminolaevulinic acid in vivo
por: Babilas, P, et al.
Publicado: (2003)

Photodynamic therapy-generated vaccines: relevance of tumour cell death expression
por: Korbelik, M, et al.
Publicado: (2007)

Aminolaevulinic acid-induced photodynamic therapy: cellular responses to glucose starvation
por: Wyld, L, et al.
Publicado: (2002)

Pegylation of charged polymer-photosensitiser conjugates: effects on photodynamic efficacy
por: Hamblin, M R, et al.
Publicado: (2003)

CD8(+) T cell-mediated control of distant tumours following local photodynamic therapy is independent of CD4(+) T cells and dependent on natural killer cells
por: Kabingu, E, et al.
Publicado: (2007)

Role of cytokines in photodynamic therapy-induced local and systemic inflammation
por: Gollnick, S O, et al.
Publicado: (2003)

Intracellular chemiluminescence activates targeted photodynamic destruction of leukaemic cells
por: Laptev, R, et al.
Publicado: (2006)

Porphyrin synthesis from ALA derivatives for photodynamic therapy. In vitro and in vivo studies
por: Perotti, C, et al.
Publicado: (2004)

Irradiance uniformity optimization for a photodynamic therapy treatment device with 3D scanner
por: Wang, Xu, et al.
Publicado: (2021)

Targeting tumour energy metabolism potentiates the cytotoxicity of 5-aminolevulinic acid photodynamic therapy
por: Golding, J P, et al.
Publicado: (2013)

B−B Bond Nucleophilicity in a Tetraaryl μ‐Hydridodiborane(4) Anion
por: Trageser, Timo, et al.
Publicado: (2020)

Photodynamic therapy effect of m-THPC (Foscan®) in vivo: correlation with pharmacokinetics
por: Jones, H J, et al.
Publicado: (2003)

Potentiation of photodynamic therapy of cancer by complement: the effect of γ-inulin
por: Korbelik, M, et al.
Publicado: (2007)

TP53 regulates human AlkB homologue 2 expression in glioma resistance to Photofrin-mediated photodynamic therapy
por: Lee, S Y, et al.
Publicado: (2010)

Effective treatment of chemoresistant breast cancer in vitro and in vivo by a factor VII-targeted photodynamic therapy
por: Duanmu, J, et al.
Publicado: (2011)

Singlet oxygen luminescence as an in vivo photodynamic therapy dose metric: validation in normal mouse skin with topical amino-levulinic acid
por: Niedre, M J, et al.
Publicado: (2005)

Correlation of real-time haemoglobin oxygen saturation monitoring during photodynamic therapy with microvascular effects and tissue necrosis in normal rat liver
por: Woodhams, J H, et al.
Publicado: (2004)

Differentiation-dependent photodynamic therapy regulated by porphobilinogen deaminase in B16 melanoma
por: Ickowicz Schwartz, D, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_4kmcusab79g9842g5401ci7tqc